Hana Alqadhi
Family · Dearborn Heights, MINPI 1699388850
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $949 and has fallen 53.3% since, to $443 in 2025.
Across 95 payments — averaging $26.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$506
- GSK$453
- AbbVie$367
- AstraZeneca$342
- BD$232
- Idorsia Pharmaceuticals US Inc$125
- plus $539 from 16 others
What the payments were for
- Speaking & faculty fees$2329%
- Food & beverage$2,33291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $506 |
| GSK | 24 | $453 |
| AbbVie | 10 | $367 |
| AstraZeneca | 11 | $342 |
| BD | 2 | $232 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Novo Nordisk | 7 | $99 |
| Amarin Pharma, Inc. | 3 | $56 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Boehringer Ingelheim | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Ironwood Pharmaceuticals, Inc | 2 | $31 |
| Pfizer | 2 | $31 |
| Boston Scientific | 1 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Bayer | 1 | $16 |
| Amgen | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,564 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 14 | $190 |
Paid to pharmacies, not to this prescriber.
Other family in Dearborn Heights
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.